PALMOPLANTAR PUSTULOSIS
Clinical trials for PALMOPLANTAR PUSTULOSIS explained in plain language.
Never miss a new study
Get alerted when new PALMOPLANTAR PUSTULOSIS trials appear
Sign up with your email to follow new studies for PALMOPLANTAR PUSTULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug hope for rare skin blister condition
Disease control TerminatedThis study tested a daily pill called deucravacitinib for people with palmoplantar pustulosis, a condition that causes painful, pus-filled blisters on the palms and soles. Only 3 adults with moderate-to-severe symptoms took the drug for 24 weeks. The goal was to see if it improve…
Matched conditions: PALMOPLANTAR PUSTULOSIS
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 17, 2026 02:44 UTC
-
Spesolimab's Long-Term safety under review for chronic skin condition
Disease control TerminatedThis study looks at the long-term safety of spesolimab for people with palmoplantar pustulosis (PPP), a skin condition causing painful blisters on hands and feet. Participants who benefited from spesolimab in earlier studies continue monthly injections for up to 5 years. Doctors …
Matched conditions: PALMOPLANTAR PUSTULOSIS
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 17, 2026 02:40 UTC
-
New drug shows promise for painful hand and foot pustules
Disease control TerminatedThis study tested the drug deucravacitinib in people with moderate-to-severe palmoplantar pustulosis, a skin condition that causes painful pus-filled blisters on the palms and soles. The goal was to see if the drug could reduce the severity of the pustules and improve quality of …
Matched conditions: PALMOPLANTAR PUSTULOSIS
Phase: NA • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated May 05, 2026 11:55 UTC